NCT06959680 The Effect of Kinesiotaping on Posture and Balance in Patients With Postural Thoracic Hyperkyphosis
| NCT ID | NCT06959680 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey |
| Condition | Kyphosis Thoracic |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-04-29 |
| Primary Completion | 2026-01-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2025-04-29 with a primary completion date of 2026-01-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of our research is to evaluate the positive effects of exercise and kinesiotaping on the thoracic kyphosis angle in young adults between the ages of 18-45 with a thoracic kyphosis angle of 40 degrees and above. Secondary aims are to investigate the effects of kinesiotaping on dynamic and static balance, pain, and quality of life in patients with thoracic hyperkyphosis.
Eligibility Criteria
Inclusion Criteria: * Being between the ages of 18-45 * Among the patients who applied to the physical medicine and rehabilitation outpatient clinic with poor posture or nonspecific back pain, the kyphosis angle was measured as ≥ 40 on the thoracic lateral radiograph * Being literate * Agreeing to participate in the research Exclusion Criteria: * Patients younger than 18 years and older than 45 years * Spinal deformity, Scheuermann disease, disc herniation * Previous spine surgery and trauma * Neuromuscular, peripheral neuropathic disease * Pregnant and postmenopausal women * Vertigo disease (central or peripheral cause) * Use of medication that may cause dizziness (in the last 3 months) * Defect of vision * Presence of physical deformity or additional disease that will prevent exercise * Active skin disease in the area where tape will be applied
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06959680 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Kyphosis Thoracic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06959680 currently recruiting?
Yes, NCT06959680 is actively recruiting participants. Contact the research team at dr.fny28@gmail.com for enrollment information.
Where is the NCT06959680 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye), Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06959680 clinical trial?
NCT06959680 is sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. The trial plans to enroll 48 participants.